Literature DB >> 27604294

5'-AMP-activated protein kinase plays an essential role in geniposide-regulated glucose-stimulated insulin secretion in rat pancreatic INS-1 β cells.

Yanan Hao1, Chunyan Liu1, Fei Yin1, Yonglan Zhang1, Jianhui Liu2.   

Abstract

Our previous work showed that geniposide affected glucose-stimulated insulin secretion (GSIS) via regulating glucose uptake and metabolism in pancreatic β cells; however, the molecular mechanisms remain largely unknown. Substantial evidence suggests that activation of 5'-AMP-activated protein kinase (AMPK) plays a central role in GSIS. Here, we aim to determine the role of AMPK on geniposide-regulated GSIS in rat pancreatic INS-1 cells. The results demonstrated that 6-[4-(2-piperidin-1-yletoxy)-phenyl]-3-pyridin-4-yl-pyrazolo[1,5-α] pyrimidine (Compound C; an AMPK inhibitor) significantly attenuated the effects of geniposide on glucose uptake, energy metabolism, and insulin secretion in INS-1 cells. We also observed that geniposide induced phosphorylation of acetyl-CoA carboxylase (ACC), a marker of AMPK activity, in a time-dependent manner in INS-1 cells; however, in the presence of Compound C, the influence of geniposide on ACC phosphorylation was obviously inhibited. Furthermore, the knockdown of AMPK protein with AMPK siRNA treatment decreased the effects of geniposide on glucose uptake, adenosine triphosphate production, and GSIS. All these data indicate that AMPK plays an essential role in geniposide-regulated GSIS in pancreatic β cells.

Entities:  

Keywords:  5′-AMP-activated protein kinase (AMPK); Acetyl-CoA carboxylase (ACC); Geniposide; Glucose-stimulated insulin secretion (GSIS)

Mesh:

Substances:

Year:  2016        PMID: 27604294     DOI: 10.1007/s11418-016-1038-5

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  35 in total

1.  Mechanisms-based therapeutic strategies in type 2 diabetes.

Authors:  Francesco Paneni; Sarah Costantino
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

2.  Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.

Authors:  Kazuko Kojima; Tsutomu Shimada; Yasuhiro Nagareda; Michiru Watanabe; Junko Ishizaki; Yoshimichi Sai; Ken-ichi Miyamoto; Masaki Aburada
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

3.  Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

Authors:  H Ilkova; B Glaser; A Tunçkale; N Bagriaçik; E Cerasi
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

4.  Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.

Authors:  Yonglan Zhang; Fei Yin; Jianhui Liu; Zixuan Liu; Lixia Guo; Zhining Xia; Jeffrey Zidichouski
Journal:  Neurochem Int       Date:  2015-04-13       Impact factor: 3.921

5.  The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.

Authors:  Catherine E Gleason; Danhong Lu; Lee A Witters; Christopher B Newgard; Morris J Birnbaum
Journal:  J Biol Chem       Date:  2007-02-07       Impact factor: 5.157

6.  Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway.

Authors:  Jianhui Liu; Fei Yin; Xuxu Zheng; Jiajia Jing; Yinhe Hu
Journal:  Neurochem Int       Date:  2007-05-06       Impact factor: 3.921

Review 7.  AMPK: an emerging drug target for diabetes and the metabolic syndrome.

Authors:  Bei B Zhang; Gaochao Zhou; Cai Li
Journal:  Cell Metab       Date:  2009-05       Impact factor: 27.287

8.  Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells.

Authors:  Lixia Guo; Xuxu Zheng; Jianhui Liu; Zhongyi Yin
Journal:  Biol Pharm Bull       Date:  2016-02-01       Impact factor: 2.233

9.  Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression.

Authors:  Gabriela da Silva Xavier; Isabelle Leclerc; Aniko Varadi; Takashi Tsuboi; S Kelly Moule; Guy A Rutter
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 10.  Targeting the AMPK pathway for the treatment of Type 2 diabetes.

Authors:  Benoit Viollet; Louise Lantier; Jocelyne Devin-Leclerc; Sophie Hebrard; Chloe Amouyal; Remi Mounier; Marc Foretz; Fabrizio Andreelli
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  5 in total

Review 1.  The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review.

Authors:  Siting Gao; Qin Feng
Journal:  Drug Des Devel Ther       Date:  2022-09-30       Impact factor: 4.319

Review 2.  Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

Review 3.  The Effects of Natural Iridoids and Anthocyanins on Selected Parameters of Liver and Cardiovascular System Functions.

Authors:  Maciej Danielewski; Agnieszka Matuszewska; Beata Nowak; Alicja Z Kucharska; Tomasz Sozański
Journal:  Oxid Med Cell Longev       Date:  2020-03-31       Impact factor: 6.543

4.  A Microdialysis in Adjuvant Arthritic Rats for Pharmacokinetics⁻Pharmacodynamics Modeling Study of Geniposide with Determination of Drug Concentration and Efficacy Levels in Dialysate.

Authors:  Ran Deng; Wei Wang; Hong Wu; Yunjing Zhang; Wenyu Wang; Li Dai; Zhengrong Zhang; Jun Fu; Feng Li
Journal:  Molecules       Date:  2018-04-24       Impact factor: 4.411

5.  Geniposide Balances the Redox Signaling to Mediate Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells.

Authors:  Chunyan Liu; Yanan Hao; Fei Yin; Jianhui Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-25       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.